Sanctuary Advisors LLC Has $27.19 Million Stock Position in Gilead Sciences, Inc. $GILD

Sanctuary Advisors LLC increased its stake in Gilead Sciences (NASDAQ:GILD) by 6.5% in Q4, acquiring 221,511 shares valued at $27.19 million. Despite this, company insiders, including CEO Daniel Patrick O’Day, sold a significant amount of shares totaling $26.7 million over the past 90 days. Gilead Sciences reported strong quarterly earnings, beating expectations, and raised its quarterly dividend, while analysts maintain a “Moderate Buy” rating with an average price target of $157.35.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin